Fisher-Jeffes Lisa, Finlay Fiona
Royal United Hospital, Combe Park, Bath.
Community Pract. 2006 Apr;79(4):121-4.
Announcement of the introduction of the five-in-one vaccine (DTaP/IPV/Hib) into the primary immunisation schedule was made on 9 August 2004. In this study all calls to the immunisation hotline were recorded between 9 August 2004 and 19 November 2004, noting who called and the nature of their enquiry. A total of 208 calls were received during the study period, and of these 23 (11.1%) related to the new vaccine. Calls were from parents (10/23, 43%), health visitors (9/23, 39%) and practice nurses (3/23, 13%). A variety of themes were covered in calls including local availability of the five-in-one vaccine, vaccine safety, mercury content and efficacy. Calls not connected with the new vaccine concerned mostly adolescent MMR (17.3%) as there was a local mumps epidemic. Others related to clarification of a child's immunisation status (13.5%), primary MMR immunisation (13.5%), vaccination scheduling or administration difficulties (12%), other schedule (12.5%) and non-schedule vaccines (2.4%), vaccine reactions (2.4%), travel vaccines (6%), BCG (6%), and a few miscellaneous queries (3%). Overall questions about the new five-in-one vaccine accounted for an extra 23 calls to the immunisation hotline during the study period (11.1% of calls).
2004年8月9日宣布将五合一疫苗（白喉、破伤风、百日咳、灭活脊髓灰质炎疫苗、B型流感嗜血杆菌结合疫苗）纳入基础免疫计划。在本研究中，2004年8月9日至2004年11月19日期间所有打给免疫热线的电话都被记录下来，记录打电话的人以及他们咨询的性质。研究期间共接到208个电话，其中23个（11.1%）与新疫苗有关。打电话的人有家长（10/23，43%）、健康访视员（9/23，39%）和执业护士（3/23，13%）。电话涉及的主题多种多样，包括五合一疫苗的本地供应情况、疫苗安全性、汞含量和有效性。与新疫苗无关的电话大多涉及青少年麻疹、腮腺炎、风疹联合疫苗（MMR）（17.3%），因为当地有腮腺炎疫情。其他电话涉及明确儿童的免疫状况（13.5%）、基础MMR免疫（13.5%）、疫苗接种安排或接种困难（12%）、其他免疫计划（12.5%）和非计划疫苗（2.4%）、疫苗反应（2.4%）、旅行疫苗（6%）、卡介苗（6%）以及一些杂项咨询（3%）。总体而言，在研究期间，关于新五合一疫苗的问题使打给免疫热线的电话额外增加了23个（占电话总数的11.1%）。
